Standout Papers

Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-react... 2003 2026 2010 2018 740
  1. Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells (2003)
    Willem W. Overwijk, Marc R. Theoret et al. The Journal of Experimental Medicine
  2. Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer (2010)
    Rajeev Shrimali, Zhiya Yu et al. Cancer Research
  3. FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors (2021)
    Leigh Marcus, Lola A. Fashoyin‐Aje et al. Clinical Cancer Research
  4. The Drug-Dosing Conundrum in Oncology — When Less Is More (2021)
    Mirat Shah, Atiqur Rahman et al. New England Journal of Medicine

Immediate Impact

23 by Nobel laureates 14 from Science/Nature 100 standout
Sub-graph 1 of 16

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Engineered skin bacteria induce antitumor T cell responses against melanoma
2023 StandoutScience
2 intermediate papers

Works of Marc R. Theoret being referenced

FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors
2021 Standout
Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells
2003 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Marc R. Theoret 4347 1098 2733 1321 135 6.5k
Jacob Schachter 6291 832 2908 2924 184 8.2k
Marcus O. Butler 4701 707 3540 1686 245 6.6k
Ravi A. Madan 4170 2170 3184 1500 284 6.5k
Bartosz Chmielowski 4349 1765 1769 2542 179 6.8k
Ahmad A. Tarhini 5490 1208 3538 2374 272 7.8k
Evan J. Lipson 5692 1543 2178 1366 123 7.4k
Luciana Molinero 6401 2140 3345 1595 101 8.9k
Jane Yuet Ching Hui 4787 1776 1607 949 98 6.4k
Amreen Husain 4562 1640 1395 1454 71 8.0k
Raanan Berger 4115 1893 1612 2143 158 7.1k

All Works

Loading papers...

Rankless by CCL
2026